In the United States, pharmaceutical advertising seems inescapable.
Since the first prescription drug ad ran in the early 1980s, the business of pharmaceutical advertising has exploded. Drug companies spent $7 billion on advertising last year, according to Statista, with most of that going to television ads; more than $287 million was spent on TV advertising for Sanofi and Regeneron’s anti-inflammatory drug Dupixent alone.
Yet most people would rather not see these ads at all. In a 2016 STAT-Harvard T.H. Chan poll, more than half of the people surveyed — 57%, to be precise — wanted drug ads to be taken off the air.
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let's stay connected!
To submit a correction request, please visit our Contact Us page.